http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109929788-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-19
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70
filingDate 2018-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109929788-B
titleOfInvention Bacterial strain with ccdB negative screening effect and construction method thereof
abstract The invention discloses a strain with ccdB negative screening effect, which is obtained by removing ccdA genes and TetR genes in F factors And (3) strain. The invention also discloses a method for constructing the strain with ccdB negative screening effect, which comprises the following steps: (1) by using Red/ET homologous recombination technology Replacing the ccdA and TetR genes on the F factor in the strain with an FRT-Kan cassette-FRT DNA sequence to obtain the F factor after gene editing; (2) providing a plasmid for expressing FLP recombinase, and deleting an exogenous sequence in the middle of two FRT sites on the F factor after gene editing through the FLP recombinase mediated recombination reaction expressed by the plasmid to obtain the strain with ccdB negative screening effect. The strain constructed by the invention has ccdB negative screening effect, can be applied to the construction of vectors based on the technologies such as Gateway and Golden Gate, and has good stable replication capacity on complex fragments such as repetitive sequences.
priorityDate 2018-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533562
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10311
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21703
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10710
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10710
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1921008
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1921008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID360610
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID53175
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID360610
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID229543
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID229543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557652
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID53175

Total number of triples: 29.